University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) — Baltimore, Maryland

University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) has participated in 1 clinical trials.

Therapeutic areas: High Risk MDS.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland Medical Center UM Greenbaum Cancer Ctr (2)?

University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) conducted?

University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) has 1 clinical trials on record. Their work covers High Risk MDS.

Is University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) accredited by Crixeo Health?

University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Maryland Medical Center UM Greenbaum Cancer Ctr (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.